PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS
NCT03268772
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Soft Tissue Sarcoma
Interventions
DRUG:
PLD and IFO
Sponsor
Fudan University